May 8, 2018 / 11:28 AM / 15 days ago

BRIEF-Axsome Therapeutics Reports Q1 Loss Per Share Of $0.19

May 8 (Reuters) - Axsome Therapeutics Inc:

* AXSOME THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q1 LOSS PER SHARE $0.19

* AT MARCH 31, 2018, AXSOME HAD $26.6 MILLION OF CASH COMPARED TO $34.0 MILLION OF CASH AT DECEMBER 31, 2017

* BELIEVES CURRENT CASH WILL BE SUFFICIENT TO FUND OPERATIONS, BASED ON CURRENT OPERATING PLANS, INTO Q3 OF 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below